We are terminating coverage on Elanix Biotechnologies AG. Investors should not rely on any previous research or forecasts.
Sign up to access
Get access to our full offering from over 30 providers
Get access to our full offering from over 30 providers
Termination of coverage
- Published:
14 Feb 2019 -
Author:
GOETZPARTNERS CORPORATE RESEARCH Research Team -
Pages:
5
We are terminating coverage on Elanix Biotechnologies AG. Investors should not rely on any previous research or forecasts.